Pharmaxis tries to dictate terms
Originally posted in Fibrosis News
This week Pharmaxis achieved a milestone almost unheard of among biotechs in recent times – the successful approval by the European drugs regulator of Bronchitol, its treatment for the debilitating disease, cystic fibrosis.
No Comments »
RSS feed for comments on this post. TrackBack URL
by Raelene
